HOME > TOP STORIES
TOP STORIES
-
TRENDS Japan Drug Makers See Rising Overseas Sales Ratios in April-June
August 11, 2015
-
ORGANIZATION Drug Pricing Tomorrow: FPMAJ’s Kamoya Says Innovation Premium Meant to Head Off Future Drug Lags
August 10, 2015
-
BUSINESS ASCO Immunotherapy Roundup - 5: Merck & Co. Discovers New Biomarkers for Keytruda
August 7, 2015
-
BUSINESS 80% Generic Target “Completely Unexpected,” and Makes Stable Growth in Japan Market Difficult: Pfizer Pres.
August 6, 2015
-
ORGANIZATION JPMA IP Committee Chair Predicts “Minimum Standard” for Data Protection Period for Drugs
August 5, 2015
-
BUSINESS Kyowa Kirin to Draw Up 5-Year Midterm Plan Focusing on Development of Global Products: President Hanai
August 4, 2015
-
ORGANIZATION “All-Japan” System Needed to Contend with Top Global Drug Makers: JPMA R&D Head
August 3, 2015
-
BUSINESS Wholesalers Must Ponder Use of Reps for New Business: Mediceo CEO
July 31, 2015
-
BUSINESS AbbVie Pres. Says Japan Attracting Foreign Investments, Confident in Hep C Drug
July 31, 2015
-
BUSINESS ASCO Immunotherapy Roundup - 4: Merck KGaA Trailing Rivals with ADCC-Inducing Avelumab
July 30, 2015
-
BUSINESS Delving into Securities Filings - 2: Drug Maker Employees Decrease 0.9% in 5 Years
July 30, 2015
-
BUSINESS New AbbVie Japan Chief Says Generics Making Room for Innovation
July 29, 2015
-
BUSINESS Delving into Securities Filings - 1: Average Salary of 25 Makers Up 4.9% in 5 Years, Generic Players Close in on Top-Tier Firms
July 29, 2015
-
ORGANIZATION Drug Pricing Tomorrow: JPA’s Abe Eyes Longer-Term Trial for Key Pricing Premium
July 28, 2015
-
BUSINESS Japan Drug Makers Should Consider Mergers, Other Deals to Survive: Chugai Chief
July 27, 2015
-
BUSINESS Toho to Differentiate Itself through Customer Support Rather than Prices: Pres.
July 24, 2015
-
ORGANIZATION Drug Pricing Tomorrow: Full Interview with Kenporen Vice President Shirakawa
July 24, 2015
-
REGULATORY Drug Pricing Organization Proposes Re-Pricing of Products with Huge Sales
July 23, 2015
-
REGULATORY Z2 Rule, DPC Incentive Need Revisions in Line with New Generic Target: MOF Budget Examiner
July 22, 2015
-
REGULATORY PAFSC’s First Committee to Discuss Actelion’s Tracleer, Other Products on July 31
July 21, 2015
ページ
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…
